Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Miglustat“
Suchtreffer
Begriffe & Kennungen
Miglustat Dipharma
Eintrag öffnenMiglustat Dipharma · 4.1 Therapeutic indications · 1
Eintrag öffnenMiglustat Dipharma · 4.3 Contraindications · 1
Eintrag öffnenMiglustat Dipharma · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenMiglustat Dipharma · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenMiglustat Dipharma · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenMiglustat Dipharma · 4.5 · Limited data suggest that co-administration of miglustat and enzyme replacement with imiglucerase in patients
Eintrag öffnenMiglustat Dipharma · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenMiglustat Dipharma · 4.8 Undesirable effects · 1
Eintrag öffnenMiglustat Dipharma · 4.8 · 6 Weight loss has been reported in 55% of patients. The greatest prevalence was observed between 6 and 12 mont
Eintrag öffnenMiglustat Dipharma · 4.8 · Adverse reactions from clinical trials and spontaneous reporting, occurring in >1 % of patients, are listed in
Eintrag öffnenMiglustat Dipharma · 4.8 · Blood and lymphatic system disorders Common Thrombocytopenia Metabolism and nutrition disorders Very common We
Eintrag öffnenMiglustat Dipharma · 4.8 · Description of selected adverse reactions
Eintrag öffnenMiglustat Dipharma · 4.8 · In 11 clinical trials in different indications 247 patients were treated with miglustat at doses of 50-200 mg
Eintrag öffnenMiglustat Dipharma · 4.8 · Miglustat has been studied in indications where certain events reported as adverse reactions, such as neurolog
Eintrag öffnenMiglustat Dipharma · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenMiglustat Dipharma · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenMiglustat Dipharma · 4.8 · Summary of the safety profile
Eintrag öffnenMiglustat Dipharma · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenMiglustat Dipharma · 4.8 · The most common adverse reactions reported in clinical trials with miglustat were diarrhoea, flatulence, abdom
Eintrag öffnen